Introduction |
|
vii | |
Editors |
|
ix | |
Contributors |
|
xi | |
1 Biopotential Amplifiers |
|
1-1 | (1) |
|
|
|
1-1 | (1) |
|
1.2 Basic Amplifier Requirement's |
|
|
1-1 | (1) |
|
|
|
|
|
1.3 Isolation Amplifier and Patient Safety |
|
|
1-8 | (1) |
|
|
1-10 | (1) |
|
|
1-11 | (1) |
|
1.6 Dynamic Range and Recovery |
|
|
1-12 | (1) |
|
Passive Isolation Amplifiers |
|
|
|
|
1-14 | (1) |
|
|
1-15 | (1) |
|
|
1-15 | (1) |
|
|
1-15 | (1) |
|
|
1-16 | (1) |
2 Bioimpedance Measurements |
|
2-1 | (1) |
|
|
|
2.1 What Is Bioimpedance? |
|
|
2-1 | (1) |
|
2.2 Conductors and Dielectrics |
|
|
2-2 | (1) |
|
2.3 Living Tissue Electrical Models |
|
|
2-4 | (1) |
|
|
|
|
|
Memristive Systems and Constant Phase Elements |
|
|
|
|
|
Schwan Multiple α, β, and γ Dispersion Model |
|
|
|
2.4 Electrodes and Electrode Polarization |
|
|
2-7 | (1) |
|
|
|
|
|
2.5 Electrode Systems and Their Sensitivity Fields |
|
|
2-9 | (1) |
|
|
|
2.6 Instrumentation and Quality Controls |
|
|
2-13 | (1) |
|
|
|
|
|
|
|
|
2-18 | (1) |
|
|
|
|
|
Converting Measured Variables to Clinical Variables or Parameters |
|
|
|
|
2-19 | (1) |
|
Volume and Flow Measurements |
|
|
|
Three Different Variables Measured with Two Electrodes |
|
|
|
Bioimpedance in Electrosurgery |
|
|
|
|
|
Electrical Impedance Tomography |
|
|
|
Some Additional Applications |
|
|
|
|
2-28 | (1) |
3 Implantable Cardiac Pacemakers |
|
3-1 | (1) |
|
|
|
3-1 | (1) |
|
|
3-2 | (1) |
|
|
3-2 | (1) |
|
|
|
|
|
|
|
|
|
|
|
|
3-9 | (1) |
|
3.5 Programmers and Ongoing Follow-Up |
|
|
3-11 | (1) |
|
|
3-12 | (1) |
|
3.7 Performance and Reliability |
|
|
3-13 | (1) |
|
3.8 Future of Pacing Technology |
|
|
3-14 | (1) |
|
|
3-14 | (1) |
4 Model Investigation of Pseudo-Hypertension in Oscillometry |
|
4-1 | (1) |
|
|
|
4-1 | (1) |
|
4.2 Automatic Oscillometry |
|
|
4-2 | (1) |
|
|
4-2 | (1) |
|
|
|
Arterial Pulse Pressure Model |
|
|
|
|
4-3 | (1) |
|
|
4-3 | (1) |
|
Control Condition Model (Normal Artery) |
|
|
|
Experimental Condition Model (Pseudo-Hypertension) |
|
|
|
|
4-4 | (1) |
|
4.7 Discussion and Analysis |
|
|
4-10 | (1) |
|
|
4-11 | (1) |
|
|
4-11 | (1) |
5 Cardiac Output Measurement |
|
5-1 | (1) |
|
|
|
5-1 | (1) |
|
5.2 Indicator-Dilution Method |
|
|
5-1 | (1) |
|
|
|
|
|
|
|
|
5-5 | (1) |
|
|
5-7 | (1) |
|
Indicator-Dilution Method for Ejection Fraction |
|
|
|
|
5-11 | (1) |
6 External Defibrillators |
|
6-1 | (1) |
|
|
|
6-1 | (1) |
|
6.2 Mechanism of Fibrillation |
|
|
6-1 | (1) |
|
6.3 Mechanism of Defibrillation |
|
|
6-2 | (1) |
|
6.4 Clinical Defibrillators |
|
|
6-3 | (1) |
|
|
6-5 | (1) |
|
|
6-5 | (1) |
|
|
6-7 | (1) |
|
|
6-7 | (1) |
|
|
6-7 | (1) |
7 Implantable Defibrillators |
|
7-1 | (1) |
|
|
|
|
7-1 | (1) |
|
|
7-2 | (1) |
|
|
|
|
|
|
|
|
7-8 | (1) |
|
|
|
|
|
|
|
|
7-9 | (1) |
|
|
|
High-Voltage Antitachycardia Therapy |
|
|
|
Low-Voltage Antitachycardia Therapy |
|
|
|
7.5 Diagnostics and Monitoring |
|
|
7-10 | (1) |
|
|
7-13 | (1) |
|
|
7-14 | (1) |
8 Implantable Stimulators for Neuromuscular Control |
|
8-1 | (1) |
|
|
|
8.1 Functional Electrical Stimulation |
|
|
8-1 | (1) |
|
8.2 Technology for Delivering Stimulation Pulses to Excitable Tissue |
|
|
8-2 | (1) |
|
8.3 Stimulation Parameters |
|
|
8-2 | (1) |
|
8.4 Implantable Neuromuscular Stimulators |
|
|
8-3 | (1) |
|
|
|
|
|
|
|
|
|
|
|
8.5 Packaging of Implantable Electronics |
|
|
8-6 | (1) |
|
|
8-7 | (1) |
|
8.7 Safety Issues of Implantable Stimulators |
|
|
8-8 | (1) |
|
8.8 Implantable Stimulators in Clinical Use |
|
|
8-9 | (1) |
|
Peripheral Nerve Stimulators |
|
|
|
Stimulators of Central Nervous System |
|
|
|
8.9 Future of Implantable Electrical Stimulators |
|
|
8-11 | (1) |
|
|
|
Sensing of Implantable Transducer-Generated and Physiological Signals |
|
|
|
|
8-12 | (1) |
|
|
8-12 | (1) |
|
|
8-13 | (1) |
|
|
8-14 | (1) |
9 Respiration |
|
9-1 | (1) |
|
|
|
9-1 | (1) |
|
9.2 Pulmonary Function Tests |
|
|
9-1 | (1) |
|
|
|
|
|
The Nitrogen-Washout Method for Measuring FRC |
|
|
|
9.3 Physiologic Dead Space |
|
|
9-9 | (1) |
|
|
9-10 | (1) |
10 Mechanical Ventilation |
|
10-1 | (1) |
|
|
|
10-1 | (1) |
|
10.2 Positive-Pressure Ventilators |
|
|
10-2 | (1) |
|
|
10-2 | (1) |
|
|
|
Adaptive Pressure Control |
|
|
|
Adaptive Support Ventilation |
|
|
|
|
|
Continuous Positive Airway Pressure in Spontaneous Mode |
|
|
|
Pressure Support in Spontaneous Mode |
|
|
|
|
|
Mandatory Volume-Controlled Inspiratory Flow Delivery |
|
|
|
Pressure-Controlled Inspiratory Flow Delivery |
|
|
|
Expiratory Pressure Control in Mandatory Mode |
|
|
|
Spontaneous Breath Delivery Control |
|
|
|
|
10-11 | (1) |
|
|
10-12 | (1) |
|
|
10-12 | (1) |
11 Essentials of Anesthesia Delivery |
|
11-1 | (1) |
|
|
|
11-1 | (1) |
|
11.2 Components of Anesthesia Care |
|
|
11-1 | (1) |
|
11.3 Who Delivers Anesthesia? |
|
|
11-2 | (1) |
|
|
11-2 | (1) |
|
11.5 Gases Used during Anesthesia and Their Sources |
|
|
11-4 | (1) |
|
Air (78% N2, 21% Op 0.9% Ar, and 0.1% Other Gases) |
|
|
|
Gas Blending and Vaporization System |
|
|
|
|
|
|
|
11.6 Monitoring the Function of the Anesthesia Delivery System |
|
|
11-10 | (1) |
|
11.7 Monitoring the Patient |
|
|
11-11 | (1) |
|
Control of Patient Temperature |
|
|
|
Monitoring the Depth of Anesthesia |
|
|
|
Anesthesia Computer-Aided Record Keeping |
|
|
|
|
|
|
|
|
|
|
|
|
11-13 | (1) |
12 Electrosurgical Devices |
|
12-1 | (1) |
|
|
|
|
12-1 | (1) |
|
|
12-1 | (1) |
|
|
12-2 | (1) |
|
12.4 Dispersive Electrodes |
|
|
12-5 | (1) |
|
|
12-5 | (1) |
|
|
12-6 | (1) |
|
|
12-7 | (1) |
|
|
12-8 | (1) |
|
|
12-8 | (1) |
|
|
12-9 | (1) |
13 Biomedical Lasers |
|
13-1 | (1) |
|
|
13.1 Interaction and Effects of UV-IR Laser Radiation on Biologic Tissues |
|
|
13-2 | (1) |
|
Scattering in Biologic Tissue |
|
|
|
Absorption in Biologic Tissue |
|
|
|
13.2 Penetration and Effects of UV-IR Laser Radiation into Biologic Tissue |
|
|
13-3 | (1) |
|
13.3 Effects of Mid-IR Laser Radiation |
|
|
13-4 | (1) |
|
13.4 Effects of Near-IR Laser Radiation |
|
|
13-4 | (1) |
|
13.5 Effects of Visible-Range Laser Radiation |
|
|
13-5 | (1) |
|
13.6 Effects of UV Laser Radiation |
|
|
13-5 | (1) |
|
13.7 Effects of Continuous and Pulsed IR-Visible Laser Radiation and Associated Temperature Rise |
|
|
13-5 | (1) |
|
13.8 General Description and Operation of Lasers |
|
|
13-6 | (1) |
|
13.9 Biomedical Laser Beam Delivery Systems |
|
|
13-7 | (1) |
|
Optical Fiber Transmission Characteristics |
|
|
|
Mirrored Articulated Arm Characteristics |
|
|
|
Optics for Beam Shaping on Tissues |
|
|
|
Features of Routinely Used Biomedical Lasers |
|
|
|
|
|
|
13-11 | (1) |
|
|
13-11 | (1) |
|
|
13-13 | (1) |
14 Measuring Cellular Traction Forces at the Micro- and Nanoscale |
|
14-1 | (1) |
|
|
|
|
14-1 | (1) |
|
14.2 Contractile Apparatus of Cells |
|
|
14-2 | (1) |
|
14.3 Design Consideration for Traction Force Assays |
|
|
14-4 | (1) |
|
14.4 Traction Force Assays for Cells |
|
|
14-5 | (1) |
|
Silicone Membrane Wrinkling |
|
|
|
Traction Force Microscopy |
|
|
|
Microfabricated Cantilever Force Sensors |
|
|
|
|
14-10 | (1) |
|
|
14-11 | (1) |
|
|
14-11 | (1) |
15 Blood Glucose Monitoring |
|
15-1 | (1) |
|
|
15.1 Historical Methods of Glucose Monitoring |
|
|
15-2 | (1) |
|
15.2 Development of Colorimetric Test Strips and Optical Reflectance Meters |
|
|
15-3 | (1) |
|
15.3 Emergence of Electrochemical Strips |
|
|
15-5 | (1) |
|
15.4 Enzyme Selectivity and Falsely Elevated Readings |
|
|
15-7 | (1) |
|
15.5 Improvements in User Interactions with the System and Alternate Site Testing |
|
|
15-7 | (1) |
|
15.6 Continuous Glucose Sensors |
|
|
15-9 | (1) |
|
|
15-11 | (1) |
|
|
15-12 | (1) |
|
|
15-12 | (1) |
|
|
15-13 | (1) |
16 Atomic Force Microscopy: Opportunities and Challenges for Probing Biomolecular Interactions |
|
16-1 | (1) |
|
|
|
|
16-1 | (1) |
|
|
16-2 | (1) |
|
|
16-2 | (1) |
|
|
16-3 | (1) |
|
|
|
|
|
|
|
|
16-5 | (1) |
|
|
16-6 | (1) |
|
Protein Aggregation and Fibril Formation |
|
|
|
Membrane Protein Structure and Assemblies |
|
|
|
|
16-9 | (1) |
|
|
|
|
|
|
|
|
|
|
|
|
16-16 | (1) |
|
|
16-17 | (1) |
17 Parenteral Infusion Devices |
|
17-1 | (1) |
|
|
|
17.1 Performance Criteria for IV Infusion Devices |
|
|
17-1 | (1) |
|
17.2 Flow through an IV Delivery System |
|
|
17-3 | (1) |
|
17.3 Intravenous Infusion Devices |
|
|
17-4 | (1) |
|
Gravity Flow/Resistance Regulation |
|
|
|
Volumetric Infusion Pumps |
|
|
|
|
|
|
|
17.4 Managing Occlusions of the Delivery System |
|
|
17-8 | (1) |
|
|
17-11 | (1) |
|
|
17-11 | (1) |
|
|
17-11 | (1) |
18 Clinical Laboratory: Separation and Spectral Methods |
|
18-1 | (1) |
|
|
|
18-1 | (1) |
|
|
18-1 | (1) |
|
18.3 Chromatographic Separations |
|
|
18-2 | (1) |
|
|
18-2 | (1) |
|
18.5 High-Performance Liquid Chromatography |
|
|
18-3 | (1) |
|
18.6 Basis for Spectral Methods |
|
|
18-4 | (1) |
|
|
18-5 | (1) |
|
|
18-6 | (1) |
|
18.9 Atomic Absorption Spectroscopy |
|
|
18-6 | (1) |
|
18.10 Turbidimetry and Nephelometry |
|
|
18-7 | (1) |
|
|
18-8 | (1) |
|
|
18-8 | (1) |
19 Clinical Laboratory: Nonspectral Methods and Automation |
|
19-1 | (1) |
|
|
19.1 Particle Counting and Identification |
|
|
19-1 | (1) |
|
19.2 Electrochemical Methods |
|
|
19-3 | (1) |
|
19.3 Ion-Specific Electrodes |
|
|
19-4 | (1) |
|
|
19-5 | (1) |
|
|
19-6 | (1) |
|
|
19-7 | (1) |
|
|
19-7 | (1) |
|
19.8 Trends in Laboratory Instrumentation |
|
|
19-8 | (1) |
|
|
19-8 | (1) |
|
|
19-9 | (1) |
20 Noninvasive Optical Monitoring |
|
20-1 | |
|
|
|
20-1 | (1) |
|
20.2 Oximetry and Pulse Oximetry |
|
|
20-1 | (1) |
|
|
|
|
|
Application and Future Directions |
|
|
|
20.3 Nonpulsatile Spectroscopy |
|
|
20-7 | (1) |
|
|
|
|
|
Near-Infrared Spectroscopy and Glucose Monitoring |
|
|
|
Time-Resolved Spectroscopy |
|
|
|
|
20-9 | (1) |
|
|
20-9 | (1) |
|
|
20-10 | (1) |
|
|
20-10 | |
Index |
|
Index-1 | |